RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A yarn about Thomas Edison and an 88 cent penny stock
Hey we can knock Bucky or me or whomever all you want but why not ever knock those who give wrong or misleading information or the company once in awhile for not following through or delivering on what should have happened a long time ago and as for shareholder value. We were at 1.91 on october 7th so now down 35% with all the good that is going on and the thought of AA or a partnership or BO. Shareholders have never gotten any upside shareholder value with this company and we all know what it is really worth if we take into account the consolidation that we had before.
On top of that it's getting closer to the year end where they will once again decide how much of a raise they all deserve for all the work they have put in. It's nice to remain positive and yes all of the trials have been positive for the most part (except for parts where they had the wrong ci which should never have happened and also not accounting for the fever issues which they already knew about) so why are we still where we are. There has to be something underlying that we are not aware of especially when comparing to all of the other companies that have been bought up.
Bottom line it is out of our control no matter what anybody thinks and things will continue on and here's hoping that they will actually get down to business on either a parnership or BO and be done with it all. And no more deceiving us on those options which they just announced as expired which was supposed to indicate that they were in a Blockout for almost a year.. Something not on the up and up or if they were then the deal is no longer there.
NIce to remain positive but at least be realistic at the same time.
So now we wait for Anal and or folfirinox panc run in results for the next opportunity.
Also as others have stated and this is where there is hope is that a partnership or BO could come at any time and that is the only thing that will save this company in respect for shareholder value.